メタ情報
| meta description平均長 | 159.64 |
|---|
| OGPありページ数 | 13 |
|---|
| Twitterカードありページ数 | 13 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 30 |
|---|
| ページあたり内部リンク平均 | 41.54 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| you | 1 |
| your | 0.633333 |
| data | 0.5 |
| website | 0.466667 |
| any | 0.4 |
| cookies | 0.365416 |
| also | 0.274062 |
| comment | 0.274062 |
| can | 0.274062 |
| personal | 0.274062 |
| may | 0.266667 |
| will | 0.235015 |
| comments | 0.228385 |
| clinical | 0.207504 |
| bring | 0.207504 |
| address | 0.2 |
| not | 0.2 |
| conditions | 0.2 |
| Institut | 0.188907 |
| leave | 0.182708 |
| site | 0.182708 |
| browser | 0.182708 |
| embedded | 0.182708 |
| login | 0.182708 |
| cookie | 0.182708 |
| information | 0.182708 |
| these | 0.182708 |
| people | 0.176809 |
| per | 0.176809 |
| liver | 0.176809 |
| years | 0.170261 |
| images | 0.166667 |
| content | 0.166667 |
| use | 0.166667 |
| Pasteur | 0.146928 |
| cutting | 0.138336 |
| Summary | 0.137518 |
| disease | 0.137518 |
| drug | 0.137518 |
| service | 0.137031 |
| see | 0.137031 |
| These | 0.137031 |
| account | 0.137031 |
| edit | 0.137031 |
| their | 0.137031 |
| accept | 0.137031 |
| names | 0.137031 |
| Epidemiology | 0.137031 |
| AMD | 0.137031 |
| ARDS | 0.137031 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| class | first | 3.780322 | 76 |
| Saint | antoine | 3.690315 | 52 |
| Calmette | Professeur | 3.660343 | 60 |
| Faubourg | Saint | 3.607336 | 56 |
| Institut | Pasteur | 3.586844 | 64 |
| Business | model | 3.564543 | 52 |
| Approach | model | 3.54994 | 52 |
| Achievements | Approach | 3.54994 | 52 |
| Achievements | Team | 3.54994 | 52 |
| Pipeline | companies | 3.54994 | 52 |
| Partners | Pipeline | 3.54994 | 52 |
| News | Partners | 3.54994 | 52 |
| anti | inflammatory | 3.533164 | 45 |
| Campus | Institut | 3.476288 | 60 |
| France | Paris | 3.376412 | 82 |
| Lutech | SATT | 3.343417 | 44 |
| Paris | Saint | 3.326103 | 68 |
| PSC | Primary | 3.31247 | 45 |
| PSC | sclerosing | 3.31247 | 45 |
| PSC | cholangitis | 3.31247 | 45 |
| per | year | 3.298335 | 72 |
| Faubourg | Paris | 3.286461 | 67 |
| Lille | Pasteur | 3.265899 | 77 |
| Today | owned | 3.264391 | 40 |
| intellectual | property | 3.25929 | 36 |
| GLP | analog | 3.25929 | 36 |
| analog | potential | 3.25929 | 36 |
| DMOAD | showing | 3.25929 | 36 |
| anabolic | catabolic | 3.25929 | 36 |
| anabolic | properties | 3.25929 | 36 |
| Berenbaum | Francis | 3.25929 | 36 |
| APHP | Sorbonne | 3.25929 | 36 |
| Milestone | now | 3.25929 | 36 |
| entering | now | 3.25929 | 36 |
| Phase | entering | 3.25929 | 36 |
| Market | study | 3.25929 | 36 |
| Market | Millions | 3.25929 | 36 |
| Kloppenburg | world | 3.25929 | 36 |
| Estimated | Kloppenburg | 3.25929 | 36 |
| Estimated | sales | 3.25929 | 36 |
| billion | worth | 3.25929 | 36 |
| Vienna | based | 3.25929 | 36 |
| Austria | Vienna | 3.25929 | 36 |
| Austria | join | 3.25929 | 36 |
| forces | join | 3.25929 | 36 |
| discover | forces | 3.25929 | 36 |
| develop | discover | 3.25929 | 36 |
| Primary | sclerosing | 3.25929 | 36 |
| cholangitis | sclerosing | 3.25929 | 36 |
| characterized | condition | 3.25929 | 36 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録